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Abstract  
 
 
DEVELOPMENT AND COMMISSIONING OF AN INDEPENDENT PEER REVIEW 
SYSTEM FOR A SMALL ANIMAL IRRADIATOR  
 
Mary Elizabeth Peters, B.S. 
Advisory Professor: Rebecca M Howell, Ph.D. 
 
Dosimetry for small animal irradiators lacks the standardization of clinical 
radiotherapy practice, yet plays a central translational role in human trial design. The 
purpose of this work was to improve the dosimetric accuracy and consistency of 
animal studies by developing an independent peer review system to verify dose 
delivery from animal irradiators.  This study focused on the development of a mouse 
phantom and characterization of the thermoluminescent dosimetry system for a 
commonly used small animal irradiator. 
First, a mouse model and irradiation stand were designed with the purpose of 
being used in a mailable audit.  Two mouse phantoms were machined from high 
impact polystyrene; one accommodated three thermoluminescent dosimeters (TLD) 
and the other an Exradin A1SL 0.053 cc ion chamber (Standard Imaging, Middleton, 
WI) for cross-comparison with the TLD.  An acrylic irradiation stand was constructed 
to allow users to align the mouse phantom to the irradiator’s isocenter.  Second, the 
mouse system was commissioned in a small animal irradiator using a 225 kVp 
beam.  A pseudo tissue-air ratio was determined using the ion chamber mouse 
phantom.  The dose rate was determined using the TG-61 “in-air” method, along 
 vii 
with the measured half-value layer of the beam.  The response of the TLD in the 
mouse phantom was characterized under identical irradiation conditions.  Lastly, the 
commissioned mouse system was mailed to two institutions to verify feasibility of the 
service. 
We designed a robust, user-friendly mouse phantom and foldable irradiation 
stand, ideal for a mail audit service.  The system was commissioned at 225 kVp in a 
small animal irradiator.   The energy correction factor for TLD in the mouse phantom 
was 0.792 (SD=0.006) relative to 60Co. This factor can be applied to validate dose 
delivered in this model of animal irradiator.  The feasibility of the independent peer 
review system was demonstrated by verifying beam output and small animal 
dosimetry for two institutions. 
We established and commissioned a methodology for independent peer 
review of mouse dosimetry for a commonly used animal irradiator.  This 
methodology can be used to characterize other commercially available orthovoltage 
irradiators.  
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Chapter 1: Introduction and Background 
 
Background to the Problem  
 
The results from pre-clinical research, i.e., animal studies, are used to assist in 
the design of clinical trials for human subjects.  Accurate and reproducible pre-clinical 
radiation biology research is essential for designing meaningful clinical trials in 
radiation oncology that will advance cancer treatments.  As described in a recent 
review article, the National Cancer Institute (NCI) is concerned with the lack of success 
of recent clinical trials (Zakeri, Coleman, & Vikram, 2018). The article analyzed results 
of recent prospective randomized trials in radiation oncology for clinical significance.  
Notably and of concern, approximately half of the clinical trials were not proven to be 
clinically significant, highlighting the need for improved clinical trial design, which 
starts with improved pre-clinical research.   
A recent NCI U01 funding opportunity announcement had explicit instructions 
requiring accurate and reproducible dosimetry for the testing of targeted agents 
administered with radiation therapy and chemotherapy in cell and animal studies 
(National Institutes of Health, 2016).  The program announcement emphasized the 
importance of robust pre-clinical studies in order to improve the potential success of 
human trials.  In order for pre-clinical work to be robust, standardization is needed.  
This need was emphasized in the program announcement, which explicitly stated, “In 
radiation studies, as in other preclinical testing, there is a need for standardization of 
assays, for the development of improved models, as well as a framework for cross-
validation of pre-clinical results.”  The program announcement addressed specific 
action items for improving standardization, including stating the “precise targeting, 
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timing, and dosing of radiation” and “ensuring accuracy and consistency of irradiation 
protocols through [National Institute of Standards and Technology (NIST)]-traceable 
dosimetry testing and ongoing validation, and detailed, translatable reporting of 
irradiation set-up details.”  Not only does the announcement state specific 
methodology, but a mandatory component of the modular budget was the inclusion of 
a minimum of fifty thousand dollars towards NIST-traceable dosimetry.  This is the first 
time that such explicit details regarding radiation dosimetry and standardization have 
been specifically defined in an NCI program announcement for molecularly targeted 
therapy in animals and cells.  This paradigm shift toward including mechanisms to 
ensure accurate radiation dosimetry in pre-clinical studies suggests that the NCI is 
concerned that failures in recent clinical trials are related to the lack of accurate and 
consistent dosimetry in those studies.  
Several studies have investigated the need for improved dosimetry reporting in 
pre-clinical studies in order to improve the translation of preclinical research into the 
clinic.  One report investigated preclinical studies for ten popular radiation dose 
enhancers (Stone et al., 2016).  The report evaluated 125 preclinical studies, 104 in 
vitro and 51 in vivo.  The studies’ methods were evaluated for clarity.  A subset of the 
methods analyzed was reporting of radiation parameters, including: radiation source 
type, energy, dose rate, setup, and equipment calibration. The percentages of in vitro 
and in vivo papers for which these radiation parameters were clearly reported are 
summarized in Table 1.  The lack of reporting of irradiation parameters is concerning 
for several reasons.  First, it makes it impossible for other researchers to reproduce 
the experiment and compare experimental results.  Second, lack of reporting makes 
it unclear whether the dosimetry within the studies was accurate.  The report’s review 
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highlights these two key concerns, stating, “with deficiencies in reporting dosimetry 
and irradiation setup, it was not possible to know whether researchers had accounted 
for such factors as dose from backscatter, uniformity of dose across the radiation field 
or through the depth of the tumor, absorption by overlying culture medium, culture 
vessel or tissues, and whether dosimetry had been carried out under the same 
conditions as the experimental setup or was traceable to equipment calibrated by 
NIST.  Lack of this information makes it impossible to replicate the studies and to 
compare results within and among laboratories.”  The results of pre-clinical research 
on very complex radiation biology mechanisms have no meaning if the dosimetry is 
incorrect and others cannot reproduce the results.  This is of particular concern for 
radiation threshold experiments, where the absorbed dose associated with a radiation-
induced effect is being reported, e.g., erythema onset (Desrosiers et al., 2013). 
 
 
 
 
 
 
 
 
 
Radiation Parameter 
Studies that Reported the Specified Parameter (%) 
In Vitro Studies In Vivo Studies 
 4 
Source 86 80 
Energy 81 63 
Dose rate 62 57 
Setup 24 55 
Equipment Calibration 8 20 
Table 1. Reporting of radiation parameters in a survey of one hundred and twenty-
five preclinical studies1 
Concerns regarding standardization in animal studies led the NCI, the 
National Institute of Allergy and infectious Diseases (NIAID), and NIST to host a 
workshop on Radiation Dosimetry Standardization in Radiobiology in September 
2011 (Desrosiers et al., 2013).  There were two major goals of this workshop.  The 
first was to highlight the need for dosimetry standardization, and the second was to 
discuss the necessary efforts for improving standardization in the future.  Workshop 
participants put forth a list of recommendations for improving standardization.  Key 
takeaways from these recommendations were the need for collaboration among 
biologists and physicists, the need for dosimetry comparison programs, and 
suggestions for the dosimetry content that should be included in radiobiology 
publications.  In regards to the latter takeaway, participants proposed four categories 
of dosimetry information be mandated for publication of pre-clinical trial data for 
                                                     
 
1 Table 1 is compiled from: 
Stone Helen B, Bernhard Eric J, Coleman C Norman, Deye James, Capala Jacek, 
Mitchell James B, Brown J Martin. Preclinical data on efficacy of 10 drug-radiation 
combinations: Evaluations, concerns, and recommendations. Transl Oncol. 
2016;9(1):46-56. doi:10.1016/j.tranon.2016.01.002 
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studies involving radiation therapy: (1) absolute dosimetry and beam calibration (2) 
methodology for determination of absorbed dose within research subjects, (3) 
specification of the radiation source, and (4) irradiation details.  
A major discussion topic at the 2011 workshop was the need for dosimetry 
comparison programs, i.e., independent peer review, specifically for radiation biology.  
Independent peer review for dosimetry is well established for megavoltage (MV) linear 
accelerators. For MV linear accelerators, independent peer review is available from 
several different agencies/groups including the International Atomic Energy Agency 
(IAEA) (Izewska, Bera, & Vatnitsky, 2002); European Organization for Research and 
Treatment of Cancer (EORTC) (Hurkmans et al., 2016); Australian Clinical Dosimetry 
Service Radiotherapy Trials Quality (ACDS) (Williams et al., 2012); Japan Clinical 
Oncology Group (JCOG) (Okamoto et al., 2018); Radiotherapy Clinical Trials: Quality 
Assurance Group (RTTQA) (Clark et al., 2015); University of Wisconsin Radiation 
Monitoring by Mail (UWRMM), (Yegingil et al., 2012,;“Radiation Monitoring by Mail 
Services,” n.d.); MD Anderson Radiation Dosimetry Services (RDS) (Aguirre et al., 
2003); and Imaging and Radiation Oncology Core (IROC) Houston QA Center 
(Aguirre et al., 2003;,Ibbott, 2010).  However, there is no parallel service offered for 
small animal irradiators.  The University of Wisconsin Accredited Dosimetry 
Calibration Laboratory (UWADCL) has assisted with a couple of small pilot mail audits 
of beam outputs for small animal irradiators.   One study by Seed et al. found that only 
four out of seven institutions were able to deliver doses within five percent of the 
prescribed dose for their radiation biology setups (Seed et al., 2016).  The second 
study by Pedersen et al. tested twelve beams at ten different institutions, and found 
that only five out of the twelve were within five percent accuracy (Pedersen et al., 
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2016).  Furthermore, six out of the twelve beams were outside of a ten percent 
accuracy criterion.  These studies demonstrate a clear need for a widely available 
independent peer review system for small animal irradiators used for radiobiological 
pre-clinical studies. 
The market for small animal irradiators has recently shifted from the use of 
isotope source irradiators to X-ray orthovoltage irradiators.  However, this shift in 
technology has not been accompanied by new procedures or any formal 
recommendations regarding calibration of such units.  Orthovoltage beam calibration 
recommendations were defined by the American Association of Physicists in Medicine 
(AAPM) Task Group 61 (TG-61) (Ma, 2001).  However, TG-61 was published more 
than 15 years ago (2001) before current orthovoltage “cabinet” irradiators were widely 
used.  There are many challenges related to applying TG-61 protocol within the 
confines of cabinet irradiator geometries as opposed to the clinical external beam 
orthovoltage radiotherapy units for which the protocol was developed.  The lack of 
calibration protocols for this specific new technology reinforces the importance of the 
workshop recommendations for the involvement of a physicist in the design and 
implementation of radiation biology research and the need for dosimetry comparison 
programs.  In the University of Wisconsin Accredited Dosimetry Calibration Laboratory 
mail audit studies referenced above, several of the institutions tested were operating 
orthovoltage small animal irradiators.  In the study by Seed et al., three of the labs 
were operating x-ray irradiators (Seed et al., 2016).  Only one of the three labs passed.  
One of the two failing labs had dose errors as large as forty-two percent.  None of the 
orthovoltage labs had physicists on staff, and two out of the three were reliant on 
manufacturer’s specifications for dosimetry.  In the study by Petersen et al., five out 
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of the twelve facilities were x-ray facilities.  Only one of these five x-ray facilities 
passed.  The average deviation between the measured and intended dose was 
seventeen percent. 
Orthovoltage Small Animal Irradiators  
 
 The need for dedicated precision irradiators for pre-clinical research and the 
subsequent onset of orthovoltage small animal irradiators is best described in a 
review article by Verhaegen et al., detailed below (Verhaegen, Granton, & 
Tryggestad, 2011).    
The past twenty years have seen major advancements in radiation therapy. 
Modern treatments utilize beam modulation and image-guidance, resulting in 
improved tumor control and reduced normal tissue complications.  These 
technological advancements in radiation therapy were not immediately matched by 
subsequent advancements in radiobiology research.  Therefore, modern treatments 
were adapted without validation in animal models.  However, in the past decade, 
several research groups developed dedicated precision small animal irradiators that 
make it possible to mimic modern radiotherapy in small animals (Verhaegen et al., 
2011).   
In order to mimic human responses using small animals, both the radiation 
beam size and energy needed to be appropriately scaled.  Treating small animals 
using clinical megavoltage (MV) photon beams is not appropriate and does not 
resemble human treatments, although this methodology was used to derive much of 
the available clinical guidelines on tumor control probability and normal tissue 
complication probability.  MV beams result in dose build-up/down gradients at tissue 
 8 
interfaces due to electronic disequilibrium.  The scale of these gradients is on the 
order of the size of small animals, making it impossible to deliver a uniform dose to 
the tumor in a mouse using megavoltage energies.  Most of the dedicated precision 
small animal irradiators that are being widely used today contain an x-ray source, 
although some use radioactive sources (Verhaegen et al., 2011).  The dominance of 
orthovoltage irradiators over active source irradiators for pre-clinical research is likely 
attributed to several factors, including: the ability to select a desired treatment 
energy from a wide range of energies, the strict regulations associated with 
operating an active source irradiator, and the need to replace radioactive sources 
due to decay.  Verhaegen et al. describes the advantages of using orthovoltage 
energies to treat small animals.  Unlike MV photon beams, orthovoltage beams 
experience minimal dose buildup effects at material interfaces, making them ideal for 
treating small animals.  Another advantage of orthovoltage beams is their sharp 
radial dose profile, reducing the dose delivered to surrounding normal tissues.  This 
advantage is critical in small animals given the small size of the target and close 
proximity of normal structures (Verhaegen et al., 2011). 
State of the art orthovoltage small animal irradiators are commercially 
available from Precision X-Ray (North Branford, CT) and Xstrahl Medical & Life 
Sciences (Camberley, Surrey) (Butterworth, Prise, & Verhaegen, 2015).  Precision 
X-Ray’s most advanced irradiator on the market is the X-RAD Small Animal 
Radiotherapy (SmART) unit (Figure 1), the successor of the X-RAD 225Cx.  The 
major competitor for the X-RAD SmART is the Xstrahl Small Animal Radiation 
Research Platform (SAARP) (Figure 2).  Both irradiators achieve sub-millimeter 
targeting accuracy, an important requirement given that entire anatomical structures 
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in mice and rats are on the order of centimeters.  The single x-ray tube in these 
irradiators is used for both imaging and therapy via interchangeable filter packs, 
enabling image-guided treatments.  They are capable of fast (approximately one 
minute) precision imaging via cone beam computed tomography (CBCT) by either 
rotating the x-ray source and detectors or rotating the animal.  Both of these systems 
also offer bioluminescent optical imaging (Verhaegen et al., 2011).  Researchers can 
inject Luciferase, a light emitting enzyme, into small animals in order to visualize 
tumor or disease (Sadikot, 2005).  The optical photons are detected using charge-
coupled device (CCD) cameras. Incorporating fast, functional imaging capabilities 
into small animal research platforms is commendable. Bioluminescent optical 
imaging has enabled researchers to assess treatment response and study adaptive 
radiation therapy.  However, researchers should be aware of the limitations of 
bioluminescent optical imaging in regards to signal localization.  Positron emission 
tomography (PET) scans have far superior localization due to coincidence detection.  
Previously acquired PET scans and scans from other modalities can be fused with 
bioluminescent optical imaging and CBCT images.  The precision on-boarding 
imaging, along with the ability to fuse previously acquired Digital Imaging and 
Communications in Medicine (DICOM) images from other modalities, enable 
targeting accuracies on the order of 100-200 m (Verhaegen et al., 2011; “X-RAD 
SmART Small Animal Image Guided Irradiation System,” n.d.). 
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Figure 1. Precision X-Ray’s X-RAD Small Animal Radiotherapy (SmART) unit2 
 
 
                                                     
 
2 Figure 1 reproduced from: http://www.pxinc.com/news/press-releases/researchers-
embrace-precision-x-ray%E2%80%99s-next-generation-igrt-system.html. Accessed June 7, 
2018. 
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Figure 2. Xstrahl's Small Animal Radiation Research Platform (SAARP)3 
Butterworth et al. reports on the capabilities of current small animal image-
guided radiotherapy devices.  Both Precision X-Ray and Xstrahl provide research 
platforms that can plan and deliver clinically relevant treatments that align with 
                                                     
 
3 Figure 2 adapted from: https://xstrahl.com/life-science-systems/muriplan/.  Accessed June 
7, 2018. 
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Phase 1 clinical trials.  Precision X-Ray offers a treatment planning software called 
SmART-Plan, developed at MAASTRO clinic (Maastricht, Netherlands).  SmART-
Plan computes dose using CBCT images and Monte Carlo simulations.  Xstrahl’s 
treatment planning software is called Muriplan.  It utilizes graphical processing units 
(GPUs) to compute dose based on advanced superposition convolution algorithms 
(Butterworth et al., 2015).  Both platforms are capable of planning and treating using 
static beams or complex arcs.  Non-coplanar therapy is also possible, as both the 
SmART and SARRP units have rotating animal platforms. Both companies offer 
motorized collimators, enabling intensity modulated radiation therapy (IMRT).  The 
SARRP unit is capable of respiratory gating combined with temperature and heart 
rate monitoring (“X-RAD SmART Small Animal Image Guided Irradiation System,” 
n.d.; “Small Animal Radiation Research Platform,” n.d.). 
While precision orthovoltage small animal irradiators are transforming 
translational radiobiology, they lack many of the capabilities of modern MV linear 
accelerators.  Small animal irradiators are not equipped with multi-leaf collimators.  
Furthermore, inverse treatment planning and automated contouring are not yet 
available.  Of greatest concern, quality assurance guidelines and methodologies for 
small animal irradiators are lacking.  Without processes and procedures for testing 
dosimetric accuracy and reproducibility, experimental results can’t be verified. 
 
Thermoluminescent Dosimetry  
 
Thermoluminescent dosimeters (TLD) are solid state, integrating passive 
dosimeters (Attix, 1986; Khan & Gibbons, 2014).  They are commonly used in 
clinical practice for skin dose measurements, brachytherapy dose-rate constant 
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measurements (Nunn et al., 2008), and of particular relevance to our work, 
independent peer review.  TLD are both practical and appropriate for independent 
peer review because of their small size, high dosimetric accuracy, and their ability to 
“hold” dose for readout at a later time.     
The American Association of Physicists in Medicine (AAPM) Task Group 191 
(TG-191) report provides recommendations to the medical physics community on the 
appropriate use of luminescent dosimeters in a clinical setting. It details the theory of 
TLD, phosphor crystals containing small impurities (Kry et al., n.d.).  These 
imperfections are utilized to measure dose.  When energy in the form of ionizing 
radiation is deposited in TLD, charges are excited and can become trapped in the 
crystal impurities.  During readout, these trapped charges are released by 
stimulating the crystal with heat, resulting in the emission of visible light.  Resulting 
luminescence is detected with a photomultiplier tube (PMT).  Finally, correction 
factors are applied to relate the energy collected to the dose delivered to the TLD 
(Kry et al., n.d.).  
TLD signal can be converted to dose using a calibration factor defined for a 
user’s specific irradiation and readout conditions.  It is typically defined using TLD 
standards, or TLD irradiated to a known dose under specific irradiation conditions in 
reference energy beam.  TLD standards are then used to determine the calibration 
factor, also referred to as the sensitivity, for each reading session.  This factor 
directly relates signal to dose under standard conditions.  As in TG-51 methodology, 
the dose under experimental conditions is calculated using a series of correction 
factors relating the experimental conditions to the TLD standards conditions 
(Almond, Biggs, & Hanson, 1999).  The following equation is used: 
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 𝐷 = 𝑀𝑐𝑜𝑟𝑟𝑁𝑘𝐹𝑘𝐿𝑘𝑄𝑘𝜃,  
where Mcorr is the corrected reading collected during the TLD readout process, N is 
the system calibration coefficient referred to above, kF is the fading correction factor, 
kL is the linearity correction factor, kQ is the beam quality correction factor, and k is 
the angular correction factor.  The details of each term in the equation are discussed 
further below (Kry et al., n.d.).   
For TLD powder, the mass of the powder needs to be accounted for since the 
amount of powder is directly related to the luminescence.  The corrected reading is 
reported as signal per unit mass.  The reading may be corrected for background 
signal by reading a TLD that has not been irradiated.  The system calibration 
coefficient, N, is often defined for each reading session by reading TLD standards.  
The calibration coefficient for the reading session is determined by dividing the dose 
delivered to the standards by the corrected reading (Kry et al., n.d.).   
Each of the “k” correction factors relates the experimental conditions to the 
standards conditions since the calibration coefficient is only valid for the irradiation 
and reading conditions of the standards.  The exponential decay of the TLD signal 
with time is referred to as fading.  Fading can be explained by the spontaneous 
release of electrons occupying shallow traps at room temperature.  A large amount 
of the TLD signal is lost in the first 24 hours after irradiation.  Fading stabilizes after 
a couple days, when the majority of the low energy traps have emptied.  Because of 
the exponential decay fading relationship, TLD are usually read about a week after 
irradiation, when the signal has stabilized.  The fading correction factor, kF, is 
needed if the time between irradiation and reading for the experimental TLD is 
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different than that of the standards.  This correction factor, as well as the other 
correction factors, are commissioned for each batch of TLD.  A batch of TLD is a 
group created from the same crystal.  Once the correction factors for the batch are 
determined, they can be assumed to be uniform (Kry et al., n.d.).   
The linearity correction factor, kL, refers to the varying sensitivity of signal with 
the dose delivered.  There is a linear response between dose and signal at low 
energies (up to 4 or 5 Gy).  However, the response becomes supralinear and 
eventually flat as the dose is increased.  This relationship is measured and plotted 
during batch commissioning.  The linearity correction factor corrects for the 
differences in sensitivity for the dose delivered to the experimental TLDs versus the 
standards (Kry et al., n.d.).   
The energy correction factor, kQ, accounts for the change in TLD sensitivity 
with beam quality.  Of particular relevance to this study, TLD over respond at low 
energies (in the orthovoltage range) relative to megavoltage energies.   Thus, when 
TLD are used to measured dose in orthovoltage irradiators, it is critical to fully and 
accurate characterize kQ.  There are two components of the energy correction factor, 
presented by the TG-191 committee: an intrinsic energy dependence and a medium-
dependent energy dependence.  The intrinsic energy dependence is the change in 
signal per dose to the detector versus energy.  It accounts for how radiation interacts 
with the crystal at different energies, i.e., the different trapping and recombination 
mechanisms in the phosphor crystal that occur at different energies.  The medium-
dependent energy dependence accounts for the fact that the TLD material is used to 
determine dose to a material of interest (usually tissue, water, or muscle).  The 
relationship between the dose delivered to TLD and the dose delivered to 
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surrounding tissue changes with energy as a result of differences in mass 
attenuation coefficients and stopping-power ratios (Kry et al., n.d.).  The large over-
response of TLD by up to 40% in the diagnostic range is primarily a result of this 
phenomenon.  The photoelectric effect is the dominating radiation interaction 
mechanism at low energies.  Its probability is related to the third power of the atomic 
number (Z3) (Khan & Gibbons, 2014).  The most commonly used TLD material, TLD-
100, is composed of lithium fluoride (LiF).  LiF has an atomic number of 8.3, as 
compared to 7.2 for soft tissue (Scarboro et al., 2011).  Therefore, the probability of 
the photoelectric effect in LiF is 1.53 times that in soft tissue.  The energy correction 
factor is not separated into its two components when measured.  An overall energy 
correction factor corrects for the differences in TLD sensitivity for the experimental 
versus standards beam quality. 
Lastly, the angular correction factor is needed if the orientation of the incident 
radiation on the experimental TLD is different from that of the standards.  However, 
because the TLD capsules used in this study are cylindrically symmetric, an angular 
correction factor is not needed. 
Radiation Dosimetry Services (RDS) Independent Peer Review  
 
 MD Anderson RDS is one of several organizations around the world that 
offers independent peer review in the form of mail audits.  Mail audits play a major 
role in improving the quality of radiation therapy centers.  RDS offers several 
independent peer review services including: beam output checks for external 
radiation therapy machines, dose verification for total body and total skin 
procedures, and dose verification for blood irradiators used by blood banks 
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(“Radiation Dosimetry Services: Mailed Thermoluminescent Dosimeters (TLD) for 
Quality Assurance,” n.d.).  Orthovoltage irradiators are among the external radiation 
therapy machines that RDS offers beam output checks for.  Orthovoltage output is 
checked by irradiating TLD capsules on top of an irradiation stand.  With the 
increased use of small animal irradiators in the past several years, RDS has 
received beam output check requests for these dedicated pre-clinical cabinet 
irradiators.  Over the past five years, RDS has been monitoring beam output of X-
RAD irradiators from several institutions with a passing criterion of 10%.  
Independent peer review of beam output ensures that cabinet irradiators are 
properly calibrated.  However, RDS does not currently have the ability to check small 
animal dosimetry.  Developing and commissioning a mouse phantom for 
independent peer review in small animal irradiators would enable RDS to more 
thoroughly test the dosimetry of pre-clinical studies. 
Statement of the Problem 
 
 In the past decade, dedicated precision animal irradiators have become 
widely available.  Today, they are commonly used for pre-clinical research.  The 
results from radiation biology studies are used to design clinical trials.  However, the 
accuracy and reproducibility of pre-clinical research is lacking.  There is no widely 
available service for independent peer review for small animal irradiators.  Small 
scale preliminary studies suggest that approximately 65-80% of institutions operating 
orthovoltage irradiations have large dosimetric inaccuracies (Pedersen et al., 2016; 
Seed et al., 2016).  The availability of independent peer review for small animal 
irradiators would improve dosimetric standardization in radiation biology 
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experiments, leading to improved success of clinical trials and advancements in 
modern radiotherapy. 
 
Project Objective 
 
The overall objective of this project was to develop and commission an 
independent peer review system for small animal irradiators.  In particular, we focused 
on a commonly used animal irradiator, the X-RAD 225Cx (Precision X-Ray, North 
Branford, CT).  Once developed, this methodology can be further expanded to include 
other types of commercially available irradiators.  
 
Hypothesis 
 
An independent peer review system for a small animal irradiator can be developed 
that has a total (1-sigma) uncertainty of less than ±10%. 
 
Specific Aims 
 
The four specific aims below were designed to test the hypothesis. 
1. To design a mouse phantom that is appropriate for a mailable peer review TLD 
audit service. 
2. To characterize the half value layer of the animal irradiator, and to determine dose 
in the animal irradiator using an ion chamber and following AAPM TG-61 protocol. 
3. To characterize the energy correction factor for TLD in the mouse phantom in the 
small animal irradiator.   
4. To conduct a feasibility study of the developed audit service by sending the 
phantoms to at least two sites to verify the output of their irradiators. 
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Mouse Phantom Design 
 
Methods 
 
3D Printed Mouse Phantom 
 
 The first approach to creating a mouse phantom was to utilize 3D printing 
technology.  A computed tomography (CT) scan of an average sized laboratory 
mouse was obtained from a radiation biology laboratory at our institution.  OsiriX 
(Bernex, Switzerland) software was used to import the CT scan and create a 3D 
model of the mouse.  The mouse model was edited using MeshLab software (Pisa, 
Italy) to remove the nose cone used to anesthetize the mouse.  The unedited and 
edited versions of the mouse model are shown in Figures 3a and 3b, respectively.  
Simplify3D software (Cincinnati, Ohio) was then used to convert the model into a 
printable file.  The mouse phantom was printed in two pieces using NinjaFlex 
material on a commercial 3D printer.   
 
Figure 3. Unedited (a) and edited (b) mouse model in MeshLab  
Machined Mouse Phantom  
 
(a) (b) 
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Based on preliminary results (see section 3D Printed Mouse Phantom below), 
we determined that a 3D printed phantom was not sufficiently robust for a mailable 
audit system and chose to move forward with a stylized, machined phantom made of 
high impact polystyrene (HIPS).  Such phantoms have been well characterized by 
the MD Anderson RDS, which has used stylized HIPS for ten years for its peer 
review service of orthovoltage energy blood irradiators.   
We aimed to develop a mouse phantom with dimensions similar to a typical 
mouse used in radiation biology experiments.  Thus, we measured the dimensions 
of five C57BL/6J strain mice (3 male and 2 female) at 8, 10, and 12 weeks of age.  
The following measurements were taken: whole-body length (from the tip of the nose 
to the start of the tail), head length, head depth, head width, chest length, chest 
depth, chest width, flank depth, and tail length.  The measurements are shown in 
Table 2.   
 
 
 
 
 
 
 
 
 
 
 
 22 
Age id  whole 
body 
length 
(mm) 
head 
length 
(mm) 
head 
depth 
(mm) 
head 
width 
(mm) 
chest 
length 
(mm) 
chest 
depth 
(mm) 
chest 
width 
(mm) 
flank 
depth 
(mm) 
tail 
length 
(mm) 
8 
weeks 
m1 87.5 27.5 12.0 15.3 29.7 15.2 19.7 13.5 65.6 
m2 83.9 27.0 11.6 14.7 27.8 13.8 20.0 12.2 67.3 
m3 85.6 27.5 11.9 15.9 19.2 14.6 19.1 11.5 69.1 
  85.7 27.3 11.8 15.3 25.6 14.5 19.6 12.4 67.3 
f1 80.5 27.2 13.4 14.7 26.1 17.5 19.7 13.2 65.3 
f2 82.1 28.1 11.7 17.5 27.7 15.1 19.1 12.1 69.2 
  81.3 27.7 12.6 16.1 26.9 16.3 19.4 12.7 67.3 
10 weeks m1 90.7 26.8 12.2 15.9 31.6 15.1 23.4 13.0 70.5 
m2 90.4 28.0 12.1 15.2 26.1 15.3 23.5 15.3 68.6 
m3 87.6 26.8 14.1 15.2 27.7 15.2 22.6 13.0 71.6 
  89.6 27.2 12.8 15.4 28.5 15.2 23.2 13.8 70.2 
f1 85.3 26.3 13.0 16.4 26.2 14.2 23.2 12.2 70.8 
f2 88.3 26.2 12.0 15.0 26.6 16.8 21.4 14.6 74.7 
  86.8 26.3 12.5 15.7 26.4 15.5 22.3 13.4 72.8 
12 weeks m1 94.8 28.7 12.8 15.2 26.4 17.0 25.0 14.4 89.7 
m2 88.9 29.1 12.0 16.3 16.3 14.9 24.1 14.1 70.2 
m3 89.9 28.9 13.7 17.0 25.4 17.1 26.2 12.7 70.7 
  91.2 28.9 12.8 16.2 22.7 16.3 25.1 13.7 76.9 
f1 84.2 26.5 10.8 13.8 24.3 15.5 20.4 12.8 67.0 
f2 85.3 27.4 12.4 15.0 25.3 14.1 22.7 13.2 70.4 
  84.8 27.0 11.6 14.4 24.8 14.8 21.6 13.0 68.7 
Table 2. Measured mouse dimensions4 
The average measurements were used to determine appropriate dimensions 
for the symmetric mouse phantom.  The shape of the mouse was simplified using a 
partial cylinder of diameter 25 mm to represent the body and a cone to represent the 
head.  The height of the phantom was 20 mm, and the length was 85 mm.  The 
basic dimensions of the phantom are shown in Figure 4. The lengths of the phantom 
                                                     
 
4 male and female mice indicated with id that begins with m or f, respectively 
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body and head are illustrated in Figure 4a. The height and width of the phantom are 
shown (as viewed from the backside) in Figure 4b. 
 
Figure 4. High impact polystyrene mouse phantom dimensions 
Results  
 
3D Printed Mouse Phantom 
 
The NinjaFlex 3D printed mouse phantom is shown in Figure 5.  The 
approach of 3D printing the phantom was not further pursued due to two key 
limitations.  First, a key aspect of mailable audits is that the phantoms be robust in 
terms of mechanical integrity because they will undergo thousands of shipments and 
irradiations.  The soft 3D printed phantom material, along with the small size of the 
extremities were not sufficiently robust.  Second, the energy dependence of the 
material must be well defined for beam energies in which it will be irradiated.  While 
the 3D printed material had been characterized for megavoltage photon and electron 
beams (Craft et al., 2018), it had not been characterized in orthovoltage beams. 
 
(a) 
(b) 
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Figure 5. 3D printed mouse phantom 
Machined Mouse Phantom  
 
Two mouse phantoms were machined from HIPS; one accommodated three 
thermoluminescent dosimeters (TLD) and the other an Exradin A1SL 0.053 cc ion 
chamber (Standard Imaging, Middleton, WI) for cross-comparison with the TLD.  The 
phantoms were designed so that the centroid of the ion chamber is at the same 
location as the center of the TLD powder in the middle TLD capsule.  The model of 
the mouse phantom that was designed to accommodate TLD and an ion chamber 
are shown in Figure 6a and 6b, respectively.      
 
Figure 6. Model of high impact polystyrene thermoluminescent dosimeter (a) and 
ion chamber (b) mouse phantoms 
(a) (b) 
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The machined mouse phantoms constructed of HIPS are robust and user 
friendly, ideal for a mail audit service.  Both the TLD and ion chamber phantoms, 
shown in Figure 7a and 7b, respectively, contain crosshairs for alignment with the 
irradiator’s isocenter using the unit’s wall lasers.  The TLD phantom was constructed 
to ensure a snug fit for the TLD capsules and to allow easy loading and unloading of 
the capsules between irradiations.  Holes of very small diameter behind the TLD 
capsule holes enable the capsules to be unloaded with the tip of a paperclip. 
 
Figure 7. High impact polystyrene thermoluminescent dosimeter (a) and ion 
chamber (b) mouse phantoms 
Irradiation Stand Design 
 
Methods 
 
 An irradiation stand was designed to ensure a reproducible set-up for the mail 
audit service.  Note that in this investigation, we focused on designing a stand for the 
X-RAD 225Cx small animal irradiator.  However, an analogous method could be 
followed to design irradiation stands for other manufacturers and models.  A box 
shaped irradiation stand was designed to allow users to align the mouse phantom to 
the irradiator’s isocenter.  Acrylic was selected as the material for the stand because 
it has a low scatter cross section and is translucent, ensuring optimal visibility during 
(b) (a) 
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setup.  A foldable design was chosen to reduce shipping costs for the service.  The 
height of the stand needed to be such that the center of the mouse phantom would 
align with the beam isocenter.  To determine the appropriate stand height, we 
therefore measured the distance from the metal plate at the base of the irradiator to 
the isocenter.  
Results 
 
A foldable irradiation stand was created as a platform for the developed 
mouse phantom.  The foldable irradiation stand was constructed out of sheets of 
Lexan 0.16 cm thick.  The stand is easily assembled using tape (Figure 8).  The 
distance from the metal plate at the base of the irradiator to the isocenter at our 
institution was measured to be 28.8 cm.  However, the variation in isocenter 
distance for different units, even of the same model, has not been characterized.  
Thus, to accommodate for possible variation in this distance, we designed a stand 
with a nominal height of 26 cm, to which the user can add sheets of acrylic or paper 
to achieve the appropriate height in their unit.  A stand width of 15 cm was selected 
because it does not interfere with the 10 cm by 10 cm irradiation field.  The platform 
that sits on top of the stand is 18 cm by 18 cm.  The developed irradiation stand 
ensures reproducibility in the irradiation setup for independent peer review. 
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Figure 8. Assembled irradiation stand 
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Chapter 3: Commissioning the Independent Peer Review 
System  
 
Determination of True Dose in the Animal Irradiator  
 
Methods 
 
Measuring Beam Output for Small Animal Irradiator 
 
Mechanical Isocenter Check  
 
Because beam output is determined at the irradiator’s isocenter, a 
mechanical isocenter check was performed prior to taking any output 
measurements.  An in-house isocenter position indicator (pointer) was inserted into 
the accessory tray that was used for this test.  As the source tube was rotated 
through 360 degrees, coincidence of the lasers with the tip of the isocenter pointer 
was checked. Agreement within 1 mm between the lasers and isocenter pointer 
throughout the gantry rotation indicated that the mechanical isocenter is correctly 
located.  Figure 9 illustrates the coincidence of the laser intersection with the 
isocenter pointer when the gantry is positioned so that the beam axis is vertically 
downwards. 
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Figure 9. Mechanical isocenter check 
 
Half-Value Layer Measurements  
 
Application of the TG-61 protocol requires accurate measurement of half-
value layer (HVL) under narrow-beam geometry (Ma, 2001).  An in-house narrow-
beam collimator was designed (by R. Tailor) to achieve true narrow-beam geometry 
in the small animal irradiator.  The collimating device consists of two Cerrobend 
plates of 1.6 mm thickness, separated by a vertical distance of 3.3 cm, with a 1.0 cm 
diameter aperture.  The removable collimator (Figure 10) was designed to be placed 
on top of a Styrofoam stand (Figure 11), which houses the attenuating material and 
the ion chamber (Exradin A1SL) according to good geometric conditions, reducing 
the amount of scattered radiation reaching the detector. The narrow-beam half-value 
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layer for the X-RAD 225Cx was measured using copper and aluminum sheets for 
the maximum beam quality, 225 kVp and 13 mA, over the course of several months. 
 
Figure 10. Schematic diagram of the narrow-beam collimator 
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Figure 11. Schematic diagram of the narrow-beam collimator on top of the 
Styrofoam stand5  
Air-kerma Calibration and TG-61 In-Air Method 
 
 Reference dosimetry of clinical orthovoltage irradiators is described in the 
AAPM TG-61 protocol (Ma, 2001).  The TG-61 report contains two dosimetry 
methods, “in-air” and “in-phantom”.  Both methodologies are based on an air-kerma 
standard, with measurements performed with an ionization chamber that has been 
calibrated in air in terms of air-kerma at a standards laboratory.  The in-phantom 
method determines absorbed dose to water at 2 cm depth within a water phantom 
that is at least 30 x 30 x 30 cm3.  We used the in-air methodology to calibrate the X-
                                                     
 
5 Dimensions are in centimeters unless stated otherwise 
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RAD 225Cx at our institution because its inner dimensions could not accommodate 
an appropriately sized phantom.  Specifically, we measured dose at a reference 
point in air to determine absorbed dose to water at the surface of a water phantom. 
The A1SL ion chamber used for determining TG-61 beam output was 
calibrated for air-kerma at the University of Wisconsin ADCL.  An air-kerma 
calibration factor relates the corrected ion chamber reading to the air-kerma, as 
shown in Equation 1: 
Equation 1: 𝑁𝐾 =  
𝐾𝑎𝑖𝑟
𝑀
  
where NK is the air-kerma calibration factor for a given beam quality, Kair is the air-
kerma at the reference point, and M is the corrected ion chamber reading at the 
reference point (Ma, 2001).  Our A1SL ion chamber was calibrated for four different 
tungsten anode orthovoltage beam qualities, listed in Table 3.  Air-kerma calibration 
factor was plotted as a function of HVL for the four beam qualities (Figure 12). The 
air-kerma calibration factor for the X-RAD 225Cx was selected from the fitted curve 
(Figure 12) for the unit’s measured HVL. 
 
Beam 
Quality  
Added 
filter 
(mm Al 
or Cu) 
HVL1 
(mm 
Al) 
HVL1 
(mm 
Cu) 
Air Kerma 
Rate 
(mGy/sec) 
Air Kerma 
Calibration 
Coefficient 
(Gy/C) 
Exposure 
Calibration 
Coefficient 
(R/C) 
UW200-M 1.00 Al 
+ 1.01 
Cu 
14.8 1.63 1.930 5.375 x 108 6.136 x 
1010 
UW120-M 3.0 Al + 
0.10 Cu 
6.77  2.365 5.355 x 108 6.113 x 
1010 
UW80-M 2.75 Al 3.00  1.821 5.453 x 108 6.225 x 
1010 
UW-60M 1.50 Al 1.65  1.796 5.615 x 108 6.410 x 
1010 
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Table 3. Air-kerma calibration coefficients measured at the University of Wisconsin 
Accredited Dosimetry Calibration Laboratory 
 
 
Figure 12. Plot of air-kerma calibration factor (NK) versus half-value layer (HVL) 
 
 The TG-61 in-air method formula (Equation 2) was used to calculate 
absorbed dose to water at the surface of a water phantom (Dw,z=0): 
Equation 2: 𝐷𝑤,𝑧=0 = 𝑀𝑁𝐾𝐵𝑤𝑃𝑠𝑡𝑒𝑚,𝑎𝑖𝑟 [(
𝜇𝑒𝑛̅̅ ̅̅ ̅
𝜌
)
𝑎𝑖𝑟
𝑤
]
𝑎𝑖𝑟
 
where M is the ion chamber reading (corrected for ion collection efficiency, polarity, 
temperature and pressure, and electrometer accuracy) at the isocenter, NK is the air-
kerma calibration factor for the unit’s beam quality (shown in Figure 12), Bw is the 
water phantom backscatter factor (TG-61, Table V), Pstem,air is the chamber stem 
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correction factor, and [(
μen̅̅ ̅̅ ̅
ρ
)
air
w
]
air
 is the mean mass energy-absorption coefficient 
ratio for water-to-air averaged over the incident photon spectrum (TG-61, Table IV) 
(Ma, 2001).  The experimental setup for TG-61 in-air measurements is shown in 
Figure 13.  The ion chamber was suspended in air at the isocenter with an in-house 
plastic holder that attaches to the collimator.  Measurements (60 seconds) were 
taken in a field size of 10 cm x 10 cm, using 225 kVp tube potential, 13 mA current, 
5 mm focal spot size, and 0.3 mm copper treatment filter. 
 
Figure 13. Photograph of experimental setup for Task Group 61 in-air calibration 
Determining Dose in the Mouse Phantom 
 
10 x 10 cm2 
cone 
isocenter 
Plastic 
holder 
A1SL 
chamber 
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 As detailed in the section above, the TG-61 in-air calibration protocol 
determines the absorbed dose to the surface of a water phantom.  However, of 
particular interest in developing independent peer review for small animal irradiators 
is the absorbed dose in a mouse phantom.  The RDS defines the TLD reader 
sensitivity factor using TLD standards irradiated in a mini-phantom in a Co-60 beam 
to a known dose to muscle.  Therefore, the dose to muscle at the location of the TLD 
in the mouse phantom was needed to commission the TLD for our independent peer 
review.  
The air-kerma at the isocenter was calculated by rearranging equation 1 as the 
product of the corrected ion chamber reading at the isocenter and the air-kerma 
calibration factor for the X-RAD 225Cx beam quality.  Because the ion chamber walls 
are thick enough to provide charged particle equilibrium in the orthovoltage energy 
range, the air-kerma is equivalent to the dose to air (Khan & Gibbons, 2014).  Equation 
3 was used to calculate dose to air at the isocenter. 
Equation 3: 𝐷𝑎𝑖𝑟(𝐺𝑦) = 𝑀𝑐𝑜𝑟𝑟(𝐶) ∗ 𝑁𝐾 (
𝐺𝑦
𝐶
) 
The definition of “dose in free space” was then used to convert dose to air to dose to 
an equilibrium mass of water (Khan & Gibbons, 2014), shown in Equation 4 below. 
Equation 4: 𝐷𝑤𝑎𝑡𝑒𝑟,𝑓𝑠 = 𝐷𝑎𝑖𝑟 ∗  [(
𝑢𝑒𝑛
𝜌
)
𝑎𝑖𝑟
𝑤
]
𝑎𝑖𝑟
  
Because dose to muscle is of interest, dose in free space to water was converted to 
dose in free space to muscle using Equation 5 below: 
Equation 5: 𝐷𝑠𝑡𝑟𝑖𝑎𝑡𝑒𝑑 𝑚𝑢𝑠𝑐𝑙𝑒, 𝑓𝑠 = 𝐷𝑤𝑎𝑡𝑒𝑟,𝑓𝑠* (
𝑢𝑒𝑛
𝜌
)
𝑤𝑎𝑡𝑒𝑟
𝑠𝑡𝑟𝑖𝑎𝑡𝑒𝑑 𝑚𝑢𝑠𝑐𝑙𝑒
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where  (
𝑢𝑒𝑛
𝜌
)
𝑤𝑎𝑡𝑒𝑟
𝑠𝑡𝑟𝑖𝑎𝑡𝑒𝑑 𝑚𝑢𝑠𝑐𝑙𝑒
 is the free-in-air ratio of the mass energy-absorption 
coefficient of International Commission on Radiation Units and Measurements 
(ICRU) striated muscle to water; these coefficients are listed in TG-61 (Table X) for 
different biological tissues as a function of HVL.  Finally, to convert from the dose in 
free space to the dose in the mouse phantom, a “pseudo” tissue-air ratio (TAR) was 
used.  The TAR accounts for attenuation and scattering of the beam in the phantom.  
It is defined as the ratio of the dose at a depth in a phantom (Dd) to the dose in free 
space (Dfs) at the same point, Equation 6 (Khan & Gibbons, 2014). 
Equation 6: 𝑇𝐴𝑅 =
𝐷𝑑
𝐷𝑓𝑠
  
The TAR was determined by taking the ratio of the ion chamber reading in the ion 
chamber mouse phantom (Figure 14a) to the reading in-air (Figure 14b) at the 
isocenter.  It should be noted that TAR is typically quoted for a specified field size, 
as the phantom was larger than the radiation field.  However, in this case, the mouse 
phantom is smaller than the radiation field size.  Therefore, TAR was defined as the 
ratio of the reading in the ion chamber mouse phantom for a field of 8.5 cm by 2 cm 
to the reading in-air for a field of 10 cm by 10 cm measured at the isocenter.  Once 
the TAR was determined, the dose to muscle at the center of the mouse phantom 
was determined by taking the product of the dose to muscle in free space and the 
TAR, as shown in Equation 7. 
Equation 7: 𝐷𝑠𝑡𝑟𝑖𝑎𝑡𝑒𝑑 𝑚𝑢𝑠𝑐𝑙𝑒,𝑚𝑜𝑢𝑠𝑒 = 𝐷𝑠𝑡𝑟𝑖𝑎𝑡𝑒𝑑 𝑚𝑢𝑠𝑐𝑙𝑒,𝑓𝑠 ∗  𝑇𝐴𝑅  
The doses above were converted to dose rates by taking the ratio of the dose to the 
irradiation time, accounting for timer error.  The mouse phantom dose rate was then 
used to determine the irradiation time needed to deliver a specified dose to muscle 
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of 300 cGy at the location of the TLD.  The TLD mouse phantom was loaded with 
three TLD, placed on the irradiation stand, and aligned to the unit’s lasers, shown in 
Figure 15. The irradiation time was selected on the animal irradiator console and the 
phantom was irradiated.     
 
Figure 14. Experimental set-up for tissue-air ratio measurements 
 
(a) (b) 
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Figure 15. Experimental setup for delivering a known dose to the 
thermoluminescent dosimeters in the mouse phantom 
Results 
 
Small Animal Irradiator Beam Output 
 
 
 Figure 16 is a plot of the half-value layer measured with copper attenuating 
sheets for each measurement date.  The average narrow-beam half-value layer 
 39 
expressed in copper was 0.857  0.002 mm Cu.  Figure 17 is the corresponding plot 
for aluminum attenuating sheets.  The average narrow-beam half-value layer 
expressed in aluminum was 10.86  0.09 mm Al. 
 
 
Figure 16. Results from narrow beam half-value layer measurements with copper 
attenuating sheets 
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Figure 17. Results from narrow beam half-value layer measurements with aluminum 
attenuating sheets 
  
 
 Figure 18 is a plot of the TG-61 output, i.e., dose rate of absorbed dose to 
water at the surface of a water phantom, measured on different dates. The average 
output over a four-month time interval was 426.1  3.9 cGy/min. 
 
10
10.5
11
11.5
12
1/1/18 2/1/18 3/4/18 4/4/18 5/5/18 6/5/18
H
V
L
 (
m
m
 A
l)
Measurement Date
 41 
 
 
Figure 18. Task Group 61 orthovoltage beam output results 
 
Dose rate in the mouse phantom 
 
 The average TAR was 1.075  0.01.  Figure 19 is a plot of calculated dose 
rate in the mouse phantom measured on different dates.  The dose rate is reported 
in dose to muscle.  The average dose rate over a four-month time interval was 341.2 
 1.2 cGy/min.    
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Figure 19. Measured dose rate in the mouse phantom 
Characterizing the TLD Energy Correction Factor  
 
Methods 
 
Method 1: Comparison of Ion Chamber Dose to TLD Dose in Small Animal Irradiator  
 
 The first method that we used to determine the TLD energy correction factor 
in the mouse phantom was to compare the ion chamber dose to the TLD dose in the 
mouse phantom.  The dose rate in the mouse phantom was determined by taking 
ion chamber measurements in the mouse phantom, as detailed above.  A known 
dose was delivered to TLD in the mouse phantom.  The TLD were read at RDS 
using a well-established independent beam output service, Radiation Dosimetry 
Services (Houston, TX), with an uncertainty of less than 1.5% (Kirby, T.H., Hanson, 
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W.F., Johnston, 1992).  The energy correction factor, kQ, was calculated (Equation 
8) by setting the ion chamber dose equal to the TLD dose, as shown below: 
𝐷𝑇𝐿𝐷 = 𝑀𝑐𝑜𝑟𝑟𝑁𝑘𝐹𝑘𝐿𝑘𝑄𝑘𝜃 
𝐷𝑖𝑜𝑛 𝑐ℎ𝑎𝑚𝑏𝑒𝑟 = 𝐷𝑇𝐿𝐷 
Equation 8: 𝑘𝑄 =
𝐷𝑖𝑜𝑛 𝑐ℎ𝑎𝑚𝑏𝑒𝑟
𝑀𝑐𝑜𝑟𝑟𝑁𝑘𝐹𝑘𝐿𝑘𝜃
 
where Mcorr is the corrected reading collected during the TLD readout process, N is 
the system calibration coefficient defined at a reference energy in Co-60, kF is the 
fading correction factor, kL is the linearity correction factor, and 𝑘𝜃 is the angular 
correction factor. 
Method 1 was performed a total of 18 times over 5 different dates.  At the 
outset of each performance, the dose rate in the mouse phantom was determined by 
ion chamber measurements.  After the dose rate was determined, the mouse 
phantom was loaded with three TLD and irradiated to a known dose. Three 
irradiations were performed for each date, with the exception of six irradiations on 
March 28, when method 2 was conducted.  The TLD energy correction factor was 
calculated for each irradiation.   
 
 
Method 2: Comparison of TLD Signal from Small Animal Irradiator to Reference Co-
60  
 
The second method that we used to calculate the energy correction factor 
utilized the inherent definition of the energy correction factor: the ratio of the dose 
per reading from irradiation at a given energy to the dose per reading from irradiation 
at a reference energy, as represented in Equation 9 (Kry et al., n.d.):  
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Equation 9: 𝑘𝑄 =  
𝐷𝑒𝑥𝑝
𝑀(𝑄)𝑒𝑥𝑝
𝐷𝑟𝑒𝑓
𝑀(𝑄)𝑟𝑒𝑓
⁄ . 
The second method for determining the energy correction factor was to compare the 
signal from TLD irradiated in the mouse phantom in a reference Co-60 beam to the 
signal from TLD irradiated in the mouse phantom in the small animal irradiator. 
 The TLD irradiations in the mouse phantom in Co-60 and the small animal 
irradiator were performed on the same day.  The TLD from both irradiations were 
read in the same reading session a week later to control for fading and sensitivity.   
 The procedure for delivering a known dose to TLD in the mouse phantom in 
the small animal irradiator is described in the section above.  The procedure for 
delivering a known dose to the TLD in the mouse phantom in Co-60 is detailed 
below.  First, the TG-51 calibration protocol was followed to calibrate the dose rate 
of the Co-60 unit (Almond et al., 1999).  Measurements were taken in a 30x30x30 
cm3 water tank at a depth of 10 cm with an 80 cm source to surface distance (SSD) 
with an Exradin Model A12 0.64 cc farmer type chamber (Standard Imaging, 
Middleton, WI) centered in a 10 x 10 cm2 field size.  The measurements taken at 10 
cm depth in the water tank were converted to dose rate using the following equation 
from TG-51 (Almond et al., 1999): 
Equation 10: 𝐷𝑤
𝑄 =  
𝑀𝑘𝑄𝑁𝐷,𝑤
𝐶𝑜−60
𝑡𝑠𝑒𝑡−𝑡𝑒𝑟𝑟𝑜𝑟
 
where Dw is the dose rate to water at the measurement point in water; M is the ion 
chamber reading corrected for incomplete ion collection efficiency, polarity effects, 
temperature and pressure, and the electrometer accuracy; 𝑁𝐷,𝑤
𝐶𝑜−60 is the absorbed 
dose to water calibration factor for the ion chamber (determined at a standards 
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laboratory); kQ is the beam quality factor, which is equal to one because the 
measurements are performed in the same energy that the calibration coefficient is 
defined in; tset is the time set on the timer, and terror is the timer error.   
Once the calibration at 10cm depth was completed, we used the following 
procedure was followed to convert dose at 10 cm depth in a water phantom to dose 
at 1 cm depth in the mouse phantom.  First, the dose rate at 1 cm in the water 
phantom (D1 cm)  was determined using published Co-60 percent depth doses (PDD) 
for the appropriate SSD and field size (Aird et al., 1996): 
Equation 11: 𝐷1 𝑐𝑚 =
𝐷𝑤
𝑄
∗𝑃𝐷𝐷1 𝑐𝑚
𝑃𝐷𝐷10 𝑐𝑚
. 
Next, the dose rate in full phantom was related to the dose rate in the mouse 
phantom by taking measurements with the A1SL ion chamber at 1 cm in the water 
tank and at 1 cm in the mouse phantom.  The ratio of these readings is the ratio of 
the backscatter factors, shown in Equation 12: 
Equation 12: 𝐵𝑟𝑎𝑡𝑖𝑜 =
𝑀𝑚𝑜𝑢𝑠𝑒 𝑝ℎ𝑎𝑛𝑡𝑜𝑚
𝑀𝑤𝑎𝑡𝑒𝑟 𝑡𝑎𝑛𝑘
. 
The dose rate in the mouse phantom was calculated by multiplying the dose rate at 
1 cm in the water phantom by the backscatter ratio, represented by Equation 13: 
Equation 13: 𝐷𝑚𝑜𝑢𝑠𝑒 𝑝ℎ𝑎𝑛𝑡𝑜𝑚 = 𝐷1𝑐𝑚 ∗ 𝐵𝑟𝑎𝑡𝑖𝑜 
Once the dose rate in the mouse phantom was determined, the irradiation 
time needed to deliver a known dose of 300 cGy to the TLD was determined.  It 
should be noted that the set time was the real time plus the measured end-effect.  
Once the time was set, the mouse phantom loaded with TLD was irradiated on top of 
the irradiation stand with 80 cm SSD to the top of the mouse phantom.  Six 
irradiations were performed, unloading and loading the TLD between irradiations. 
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On the same date (March 28, 2018) as the mouse phantom irradiations in Co-
60, irradiations in the X-RAD 225Cx were performed.  Ion chamber measurements 
were taken to determine the dose rate in the mouse phantom.  Then, a known dose 
was delivered to the TLD in the mouse phantom in the small animal irradiator.  Six 
irradiations were performed. 
The TLD irradiated in Co-60 and the TLD irradiated in the small animal 
irradiator were read in the same session.  The energy correction factor for Method 2 
was calculated for each irradiation using the following equation: 
Equation 14: 𝑘𝑄 =  
(
𝐷𝑚𝑜𝑢𝑠𝑒 
𝑀𝑐𝑜𝑟𝑟∗𝑘𝐹∗𝑘𝐿) 
⁄ )
𝑋𝑅𝐴𝐷
(
𝐷𝑚𝑜𝑢𝑠𝑒
𝑀𝑐𝑜𝑟𝑟∗𝑘𝐹∗𝑘𝐿) 
⁄ )
𝐶𝑜−60
 
where Dmouse is the measured dose to muscle to the mouse phantom in cGy/min.  
Therefore, the energy correction factor is the ratio of the dose per corrected TLD 
signal for 225 kVp compared to reference Co-60. 
 
Results  
 
The average TLD energy correction factor for each irradiation date is plotted 
in Figure 20.  The error bars represent the standard deviation between irradiations 
for a given date.  The average TLD energy correction factors derived from Methods 
1 and 2 were 0.792  0.006 and 0.791  0.006, respectively. An unpaired t-test 
yielded a two-tailed P value of 0.8783, indicating that there is no statistically 
significant difference between the results from Methods 1 and 2.  Therefore, the 
average energy correction factor of 0.792 can be used to verify dose delivered by 
users of the service. 
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Figure 20. Comparison of Methods 1 and 2 for determining the energy correction 
factor for thermoluminescent dosimeters in the mouse phantom 
 
Statistical Analysis/Uncertainty in the Developed Independent Peer Review System 
 
Methods 
 
An uncertainty analysis in the TLD mail audit service was conducted 
according to the methodology presented in Kirby 1992 (Kirby, T.H., Hanson, W.F., 
Johnston, 1992).  This methodology computes the uncertainty in the determination 
of dose using TLD by means of the TLD dose formula.  It combines uncertainties in 
measured TL signal, the system calibration factor, and each k-correction factor, 
assuming that each is independent and normally distributed.  The total uncertainty is 
then determined by the quadrature sum of the individual uncertainties, as 
0.75
0.8
0.85
2/1/18 3/3/18 4/2/18 5/2/18
k
Q
Measurement Date
Method 1
Method 2
 48 
represented in the equation below (Equation 4, Kirby 1992), and where a prime (‘) is 
used to represent factors relating to TLD standards, 
Equation 15: 𝑠𝐷
2 = (𝑠𝑀
𝜕𝐷
𝜕𝑀
)
2
+ (𝑠𝐷′
𝜕𝐷
𝜕𝐷′
)
2
+ (𝑠𝑘𝑄
𝜕𝐷
𝜕𝑘𝑄
)
2
+ (𝑠𝑀′
𝜕𝐷
𝜕𝑀′
)
2
+
(𝑠
(
𝑘𝐹
𝑘
𝐹′
)
𝜕𝐷
𝜕(
𝑘𝐹
𝑘
𝐹′
)
)
2
+ (𝑠
(
𝑘𝐿
𝑘
𝐿′
)
𝜕𝐷
𝜕(
𝑘𝐿
𝑘
𝐿′
)
)
2
. 
The uncertainty in the TLD energy correction factor, kQ, was calculated by 
combining our measurement uncertainty in the calculated value of kQ and the 
uncertainty in the measured ion chamber dose reported in TG-61 (Ma, 2001, Table 
III).  All other uncertainties in the TLD dose factors were taken directly from the work 
of AAPM Task Group 91 (Kry et al., n.d., Table 6.2) .  The total uncertainty in the 
developed peer review service was then calculated using equation 15. 
 
Results 
 
The uncertainty in the developed mail audit service was determined (Table 4).  
The resulting analysis indicated that the developed independent peer review service 
has a 1-sigma uncertainty of 4.2%.  However, this uncertainty is only applicable if 
the HVL has been appropriately measured under narrow-beam geometry.  The TLD 
energy correction factor varies greatly with HVL in the orthovoltage energy range 
(Kry et al., n.d.).   
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Variable Uncertainty (%) 
D0 0.6 
M0 0.7 
Mraw 1.7 
kL 0.1 
kF 0.7 
k 0.0 
kQ 3.7 
Total (1-sigma) 4.2 
Total (2-sigma)  8.5 
Table 4. Uncertainty budget for the developed independent peer review system for 
the X-RAD 225Cx 
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Chapter 4: Conducting a Pilot Study  
 
Measurements on another X-RAD 225Cx unit 
 
Methods 
 
In order to determine the variability in X-RAD 225Cx units and assess the 
feasibility of the independent peer review system, we collaborated with an X-RAD 
225Cx user at another academic institution; hereafter, referred to as Institution A (for 
anonymity). 
We were interested in comparing the beam output and mouse dosimetry 
measured in our irradiator to that of Institution A’s irradiator.  First, the narrow-beam 
HVL was determined and TG-61 output measurements were taken (following the 
previously described methods).  Second, once the beam output was determined, ion 
chamber measurements in the mouse phantom were acquired to determine absolute 
dosimetry in the mouse phantom.  Although MD Anderson and Institution A have 
identical irradiator models, the interior dimensions of the unit were not the same.  
The distance from the metal platform at the bottom of the irradiator to the isocenter 
is shorter by a couple centimeters in Institution A’s irradiator.  Therefore, the TAR 
experimental setup differed from that used at our unit because the irradiation stand 
was too tall to place the mouse phantom at the isocenter.  The setup was modified 
by placing the mouse phantom on the animal platform and adjusting the stage to 
place the ion chamber at isocenter (Figure 21).     
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Figure 21. Experimental setup for pseudo tissue air ratio measurements in the 
mouse phantom at Institution A 
 Once the dosimetry in the mouse phantom was characterized with ion 
chamber measurements, TLD were irradiated to a known dose in the TLD mouse 
phantom according to Method 1 above in order to characterize the TLD energy 
correction factor.  The TLD in the phantom were centered to the isocenter of the unit 
using the adjustable animal stage. 
Results 
 
 Although the two animal irradiators are the same model, their beam qualities 
differed.  This is likely the result of slight differences in the x-ray tube and filtration of 
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each unit. The measured beam quality of Institution A’s irradiator was higher than 
that of our irradiator.  The narrow-beam HVL of Institution A was 0.966 mm Cu and 
11.49 mm Al; 12.9% and 5.4% (respectively) higher than our institution’s HVL.  The 
TG-61 output (absorbed dose to the surface of a water phantom) of Institution A was 
370.0 cGy/min; 13.1% lower than our institution’s average output.  The pseudo TAR 
was 1.068, which is within the measurement range for our unit.  As expected from 
the lower TG-61 output, the dose rate in the mouse was 13.5% lower, measuring 
294.8 cGy/min to muscle.   
Because the energy dependence of the ion chamber is negligible, there is no 
need for an ion chamber energy correction factor.  This not the case for TLD 
dosimetry, where the sensitivity is dependent on the energy and particularly so in the 
orthovoltage energy range.  The energy correction factor of the TLD in the mouse 
phantom was determined using Method 1.  The average energy correction factor for 
Institution A was 0.811  0.003.  This energy correction factor is 2.4% higher than 
that of our institution (Figure 22).  The higher correction factor means that the 
overresponse of TLD is lesser for Institution A; this is to be expected for higher beam 
qualities.  Less of a correction is needed the closer the energy is to reference Co-60.  
The results of the feasibility measurements indicate the importance of properly 
characterizing the narrow-beam HVL for accurate TLD dosimetry. 
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Figure 22. Comparison of thermoluminescent dosimeter energy correction factors 
determined for X-RAD 225Cx animal irradiators at MD Anderson and Institution A 
 
 
Mail Audit Feasibility Study  
 
Methods  
 
 In order to test the feasibility of the developed mail audit service, we 
conducted two test audits carried out at two different institutions.  To each institution, 
we sent the mouse phantom, irradiation stand, an irradiation data form (Figure 23), 
and irradiation instructions (Figure 24).  They were asked to deliver 300 cGy to the 
center of the mouse phantom.    
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MONITORING OUTPUT OF AN ORTHOVLTAGE X-RAY  
BEAM FOR A SMALL ANIMAL IRRADIATOR 
 
 
Institution: #              -            Date Mailed:  
 
 
Date of Irradiation:                              
 
 
Person(s) Irradiating dosimeters:  
 
Primary Physicist:  
 
Physicist Email:       Phone Number:  
 
Radiation Machine (manufacturer/model):    Serial Number:  
 
kVp:       HVL:  
 
 
Mouse Phantom Irradiation Conditions 
 
 
Field size:         x                     cm2    OR        cm diameter circle 
 
 
Timer setting:    sec 
 
Timer/end error:    sec  
 
Dose delivered:    cGy  muscle 
 
       soft tissue 
 
       water 
Backscatter factor:  
 
 
 
 
 
Figure 23. Irradiation data form used for independent peer review feasibility studies 
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SMALL ANIMAL IRRADIATOR INDEPENDENT PEER REVIEW INSTRUCTIONS 
 
INSTRUCTIONS FOR IRRADIATING TLD IN MOUSE PHANTOM 
 
1. Assemble the irradiation stand as follows. Unfold the four legs into the shape 
of a rectangle and secure with a piece of tape.  Place the platform top on the 
legs. The assembled stand is shown in the Figure 1. 
 
 
 
 
 
 
2. Place the assembled stand on the metal surface at the bottom of the 
irradiator.  Place the mouse phantom loaded with TLD on top of the irradiation 
platform.  Raise the height of the stand by adding paper underneath.  
Continue adding paper until the TLD are at the unit isocenter height, indicated 
by alignment of the horizontal side crosshair on the mouse with the horizontal 
laser (Figure 2).  Once the height is correct, align the mouse phantom in all 
three dimensions.  All crosshairs should coincide with the unit lasers (Figure 
3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3- mouse phantom 
crosshairs aligned with 
irradiator lasers 
Figure 2- proper stand height 
has been reached, indicated 
by alignment of horizontal 
cross-hair with laser 
Figure 1- Assembled irradiation stand 
and platform for mouse phantom 
irradiation 
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3. Place the treatment filter and the 10 cm x 10 cm cone in the accessory tray.  
The complete irradiation setup is shown in Figure 4. 
 
 
 
 
 
 
4. Set the irradiator to 225 kVp and 13 mA.  Determine the irradiation time 
needed to deliver 300 cGy at 1 cm depth to the center of the mouse at the 
isocenter for a 10 cm x 10 cm field size.  Irradiate the phantom.   
 
5. Complete the TLD datasheet.  Fill in all requested information, as incomplete 
forms will delay the processing of your TLD.  Please send back the TLD via 
regular U.S. mail using the address label provided.  TLD cannot be read until 
7 days after irradiation.  If you wish to return TLD by an express or direct 
carrier, use the following address: Radiation Dosimetry Services, 8060 
El Rio Street, Houston, TX 77054.  If you have any questions, please call 
Radiation Dosimetry Services (RDS) at (713) 745-8999 or you may e-mail us 
at RDS@mdanderson.org. 
 
 
 
 
 
Figure 24. Instruction form used for independent peer review for feasibility studies
Figure 4- Setup for Mouse Phantom 
Irradiation 
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Results 
 
Mail Audit Results for Institution A 
 
 We selected institution A as one of the mail audit participants, since we had 
fully characterized their TLD dosimetry.  The physicist responsible for the irradiator 
performed the mail audit.  He specified that he delivered 300 cGy to water to the 
mouse with a backscatter factor of 1.35.  The TLD were later read by RDS.  Using 
our measured energy correction factor for institution A of 0.811, the calculated TLD 
dose was 224.9 cGy to water.  The TLD dose was 25% lower than Institution A’s 
specified dose of 300 cGy.   
 After follow-up with Institution A, we identified that they had treated the peer 
review output check as a TG-61 calibration check, rather than a mouse dosimetry 
check.  Their irradiation time was selected based on the dose rate to the surface of a 
full water phantom, rather than the dose rate at 1 cm depth in a mouse.  We 
converted Institution A’s specified dose to the dose to the mouse phantom by 
accounting for the incorrect backscatter factor using Equation 16: 
Equation 16: 𝐷𝑚𝑜𝑢𝑠𝑒 =
𝐷𝑓𝑢𝑙𝑙 𝑝ℎ𝑎𝑛𝑡𝑜𝑚
𝐵𝐴
∗ 𝑇𝐴𝑅 
where Dfull phantom is Institution A’s specified dose of 300 cGy to water, BA is institution 
A’s specified backscatter factor of 1.35, and TAR is our measured backscatter in the 
mouse.  Dmouse was calculated to be 238.9 cGy to water.  Using an institution 
specified dose of 238.9 cGy, the calculated TLD dose was 229.6 cGy to water (using 
linearity correction factor based on Dmouse).  The calculated TLD dose was 3.9% 
lower than Dmouse.   
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While this mail audit feasibility test demonstrated that Institution A has a 
properly calibrated unit, it did not answer the important question regarding whether 
the institution could deliver a specified dose to a mouse (or mouse phantom).  Thus, 
we again followed-up with the physicist at Institution A and asked how he would 
determine the time needed to deliver 300 cGy to a mouse.  He responded that an in-
house Monte Carlo treatment planning software is used.  Based on this feedback, 
we determined that a more appropriate test of small animal dosimetry would be an 
end-to-end test.  For this type of test, we would instruct the user to image, treatment 
plan, and irradiate the phantom on the animal stage as they would a real mouse.   
Mail Audit Results for Institution B 
 
 The mail audit was tested at a second institution, hereafter referred to as 
Institution B.  A technician performed the irradiation at Institution B, rather than a 
medical physicist.  Because some small animal irradiator users do not have 
physicists involved in the dosimetry, it is important that our audit procedures are 
easy to follow for both types of users.  Based on the feedback from the mail audit 
with Institution A, we decided to have Institution B irradiate the mouse phantom as 
they would a real mouse, rather than following the original procedure (Figure 24).  
The institution imaged the phantom with on-board CBCT, developed a single-beam  
treatment plan to deliver 300 cGy to water at the location of the TLD capsules, and 
delivered the treatment.  The TLD were later read by RDS, and it was determined 
that the TLD received a dose of 367.7 cGy to water, 22.6% higher than the specified 
dose.  After contacting the institution and investigating the dosimetric discrepancy, it 
was determined that the dose rate that was used to irradiate the phantom was for an 
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incorrect field size, 10 mm x 10 mm rather than 10 cm x 10 cm.  The institution was 
asked to repeat the mail audit.  The TLD measured dose from the repeat mail audit 
was 309.7 cGy to water, 3.2% higher than the specified dose.   
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Chapter 5: Conclusions 
 
General Review 
 
 We hypothesized that an independent peer review system for a small animal 
irradiator could be developed that has an uncertainty of less than ±10%.  
Specifically, that a mail audit service could be created with an action criterion of 
±10%, meaning that mail audit users would be contacted by RDS technical staff if 
TLD discrepancies were outside of this criterion and a repeat irradiation would be 
suggested.  This hypothesis was reasonable and perhaps overly permissive given 
that the experimental uncertainties in TLD dose measured using the RDS protocol 
are less than 1.5% (Kirby, T.H., Hanson, W.F., Johnston, 1992). 
Our mail audit results indicated that two institutions were able to deliver a 
specified dose to the mouse phantom within ±5%, which is consistent with the 1-
sigma uncertainty of 4.2% in the developed independent peer review service.  
However, it is important to note that the narrow-beam HVL was properly 
characterized by a physicist (with good narrow beam geometry) at both mail audit 
institutions.  The TLD energy correction factor varies greatly with HVL in the 
orthovoltage energy range (Kry et al., n.d.).  A comparison of measurements at MD 
Anderson and Institution A indicate that a difference in HVL as small as 0.1 mm Cu 
can result in a 2.5% difference in TLD energy correction factor.  These differences 
can only be accounted for if the HVL is determined under narrow-beam geometry.  
However, many institutions do not measure HVL under narrow-beam geometry.  In 
fact, many users do not measure HVL at all, but rather rely on manufacturer 
specifications (Seed et al., 2016).  Therefore, while the output checks for the two 
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institutions evaluated in our feasibility study were within 5%, given the additional 
uncertainty in the HVL data from different institutions, a mail audit criterion of ±10% 
for the X-RAD 225Cx irradiator is more appropriate.  Based on the measured 
variation in kQ with HVL, a 1-sigma uncertainty of 10% is appropriate for beam 
qualities between 0.65 – 1.15 mm Cu HVL. 
 
Future Work 
 
The feasibility studies highlighted the importance of both beam output and 
end-to-end testing services for independent peer review.  Moving forward, RDS will 
offer peer review services for both in-air output checks (preliminary results, Appendix 
B) and mouse phantom end-to-end dosimetric verification.  
While TLD energy correction factors have been characterized versus HVL for 
clinical orthovoltage irradiators, further characterization is needed for cabinet 
irradiators.  The narrow-beam HVL and TLD dosimetry both in-air and in-mouse 
phantom should be characterized for other X-RAD 225Cx irradiators in use.   
This thesis work determined the TLD energy correction factor in the mouse 
phantom for a 10 cm x 10 cm field size.  Future studies should be conducted to 
determine the variation of the TLD energy correction factor for different field sizes.  
While a 10 cm x 10 cm field size may be used for mouse total body irradiation, 
radiobiology studies typically use smaller field sizes to target localized regions of 
disease.  Characterizing the TLD energy correction factor would allow researchers to 
test the dosimetry for their specific irradiation protocols. 
Lastly, the methodology presented in this work should be expanded to other 
small animal irradiator models so RDS can provide more comprehensive service.  
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Given the apparent need for dosimetric standardization in small animal dosimetry 
and the lack of physics involvement, expanding the independent peer review service 
to include on-site visits for institutions with large dosimetric discrepancies will also be 
investigated. 
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Appendices 
 
Appendix A: Effect of half-value layer geometry on TG-61 output 
 
Methods  
 
TG-61 requires accurate measurement of HVL under narrow-beam geometry. 
An in-house narrow-beam collimation device with a removable Cerrobend collimator 
(R Tailor) was used to determine the effect of narrow-beam collimation on TG-61 
output.  HVL measurements were taken with (Figure A-1a) and without (Figure A-1b) 
the narrow-beam collimator.  The TG-61 in-air method was conducted to determine 
the effect of narrow-beam collimation on beam output. 
 
 
Figure A-1. (a) Experimental setup for measuring half-value layer under narrow-
beam geometry, and (b) experimental setup for measuring half-value layer under 
good geometry 
(a) (b) 
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Results  
 
The narrow-beam collimated HVL was determined to be 0.86 mm Cu and 
10.82 mm Al.  The half-value layer under good geometry, without narrow-beam 
collimation, was determined to be 0.91 mm Cu and 12.97 mm Al.  The 6%-20% 
increase in half-value layer when the narrow-beam collimator is not used can be 
attributed to an increase in scattered dose reaching the ion chamber.  The TG-61 
“in-air” method was used to determine absorbed dose to water at the surface of a 
water phantom for each half-value layer result.  An absorbed dose to water rate of 
436.1 cGy/min and 435.5 cGy/min was determined for the narrow-beam geometry 
and good geometry, respectively.  These results are shown in Table A-1. 
 With narrow-beam 
collimation 
Without narrow-beam 
collimation 
Copper HVL (mm Cu) 0.86 0.91 
Aluminum (HVL) 10.82 12.97 
TG-61 Output (cGy/min) 436.1 435.5 
Table A-1. Impact of narrow-beam collimation on Task Group 61 output 
Using our narrow-beam collimation device resulted in the most accurate dose 
rate calculation for the X-RAD 225Cx small animal irradiator.  However, using good 
geometry without narrow-beam collimation proved to have a minimal impact (0.14%) 
on the resulting calibrated output.  Therefore, it can be concluded that making a 
narrow-beam collimation device for HVL measurements of small animal irradiators is 
not necessary for proper ion chamber dosimetry.  However, properly characterizing 
the HVL according to narrow-beam geometry is important for TLD dosimetry, as 
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there is a steep response between HVL and the TLD energy correction factor at 
orthovoltage energies. 
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Appendix B: Beam Output Check for small animal irradiators with In-Air TLD 
 
Determining In-Air TLD Energy Correction Factor for X-RAD 225Cx 
 
Methods  
 
 RDS offers independent peer review of beam output for orthovoltage beams 
(typically for clinical units) with a passing criterion of  10%.  The RDS has 
characterized the TLD energy correction factor in-air versus HVL measured in mm 
Cu (Figure B-1).  The HVL expressed in copper was converted to aluminum using 
BJR 25 published data (Aird et al., 1996) (Figure B-2).  The RDS has monitored 
beam output of the X-RAD 225Cx and X-RAD 320 small animal irradiators for three 
institutions over the last decade for HVL ranging from 0.9-1.035 mm Cu and 2.63-3.1 
mm Al.  A total of 20 mail audits between the three institutions has been performed.  
Every mail audit has passed the  10% criterion.  The average ratio of TLD 
measured dose to institution stated dose was 0.979  0.027.  The average absolute 
percent difference was 2.8  1.8%.   
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Figure B-1. Plot of RDS data for thermoluminescent dosimeter energy correction 
factor versus half-value layer measured with copper attenuating sheets 
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Figure B-2. Plot of RDS data for thermoluminescent dosimeter energy correction 
factor versus half-value layer expressed in millimeters of aluminum 
 
 The TLD energy correction factor in-air in our X-RAD 225Cx unit and 
Institution A’s unit was determined according to Method 1 presented in Chapter 3.  
TG-61 output measurements were converted to dose in free space to muscle.  
Measurements were taken with the A1SL chamber free in-air at the isocenter for a 
10 cm x 10 cm field size, 225 kVp tube potential, and 13 mA tube current.  Once the 
dose rate was determined with ion chamber measurements, TLD were suspended 
in-air from the irradiation stand using tape, aligned to the isocenter, and irradiated to 
a known dose (Figure B-3).  The TLD were read, and the measured TLD dose was 
compared to the ion chamber dose to determine the TLD energy correction factor 
(Method 1). 
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Figure B-3. Experimental setup for irradiating thermoluminescent dosimeters in-air  
Results 
 
At MD Anderson, ion chamber measurements and TLD irradiations in-air 
were performed on five dates to characterize the TLD energy correction factor.  The 
average dose rate in free space to muscle measuring with the ion chamber was 
317.6  3.2 cGy/min.  The TLD energy correction factor was 0.797  0.016.  This is 
less than 1% different from the TLD energy correction factor in-mouse. 
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Institution A’s TLD energy correction factor in-air was 0.831  0.008.  This is 2.5% 
different from Institution A’s correction factor in-mouse.  The in-air TLD energy 
correction factor data is shown in Figure B-4.   
 The TLD Energy correction factors for MD Anderson and Institution A were 
compared to the values RDS uses for orthovoltage beam output.  Based on Figure 
B-1, MD Anderson’s TLD energy correction factor should be 0.754 and Institution A’s 
should be 0.764.  Therefore, using the RDS orthovoltage energy correction factor 
data for the X-RAD 225Cx for MD Anderson and Institution A would result in 
measured TLD errors of 5.4% and 8.0% respectively.  These differences are likely 
due to the differences in scatter environment of cabinet irradiators compared to 
clinical orthovoltage irradiators.  This result highlights the need to characterize the 
TLD energy correction factor versus HVL for small animal irradiators. 
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Figure B-4. Thermoluminescent dosimeter energy correction factors in-air 
Mail Audit Beam Output Checks for X-RAD 225Cx 
 
Methods 
 
 Along with the in-mouse mail audit, Institutions A and B were asked to 
performing beam output checks with TLD suspended in-air.  Figure B-5 contains the 
irradiation instructions for the output check.  The institutions were asked to deliver 
300 cGy in-air at their isocenter. 
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MONITORING OUTPUT OF ORTHOVOLTAGE BEAM FROM SMALL ANIMAL 
IRRADIATOR 
 
INSTRUCTIONS FOR IRRADIATING TLD IN-AIR 
 
1. Take the stand and the mouse phantom out of the irradiator.  Remove the top 
platform on the irradiation stand, leaving just the legs of the stand.  Place a 
long piece of tape across the top, as shown in Figure 1 below.   Make sure 
the tape is snug and doesn’t sag. 
 
 
 
 
 
 
2. Stick the three TLD capsules (colored plugs aligned in the same orientation) 
on a piece of tape and secure to the tape on the stand, as shown in Figure 2 
below. 
 
 
Figure 1- Secure piece of tape 
across the irradiation stand 
 73 
 
 
 
 
 
3. Place the stand inside the irradiator on the paper.  Remove the 10 cm x 10 
cm cone.  Add more paper until the center of the TLD powder is aligned to the 
horizontal laser.  Once you have reached the correct height, move the stand 
until the center of the TLD powder is at the isocenter, indicated by alignment 
with all of the lasers, shown in Figure 3 below. 
 
 
 
 
 
4. Insert the 10 cm by 10 cm cone.  The irradiation setup is shown in Figure 4 
below.  Set the irradiation time to deliver a dose in free space of 300 cGy at 
the location of the TLD. 
 
 
Figure 2- TLD capsules 
secured to irradiation stand. 
Figure 3- Aligning the TLD 
powder to the unit isocenter 
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5. Complete the TLD datasheet.  Fill in all requested information, as incomplete 
forms will delay the processing of your TLD.  Please send back the TLD via 
regular U.S. mail using the address label provided.  TLD cannot be read until 
7 days after irradiation. 
If you wish to return TLD by an express or direct carrier, use the 
following address: Radiation Dosimetry Services, 8060 El Rio Street, 
Houston, TX 77054. 
If you have any questions, please call Radiation Dosimetry Services (RDS) at 
(713) 745-8999 or you may e-mail us at RDS@mdanderson.org. 
 
 
Figure B-5. Beam Output Check Instructions 
Results 
 
 Both Institutions A and B stated that the TLD received 300 cGy to water.  The 
TLD measured dose for Institution A was 305.2 cGy to water; the ratio of measured 
dose to institution stated dose was 1.02.  The TLD measured dose for Institution B 
was 299.5 cGy to water; the ratio of measured dose to institution stated dose was 
0.99.  Both institutions passed the beam output check well within the 10% criterion. 
  
Figure 4- Setup for in-air TLD 
irradiation 
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